Measuring disease progression in frontotemporal lobar degeneration: A clinical and MRI study

Neurology

Volumn 74, Issue 8, 2010, Pages 666-673

  Gordon, E ^a   Rohrer, J D ^a   Kim, L G ^a   Omar, R ^a   Rossor, M N ^a   Fox, N C ^a   Warren, J D ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN ATROPHY; COGNITION; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGRESSIVE NONFLUENT APHASIA; SEMANTIC DEMENTIA;

EID: 77649176434     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3181d1a879     Document Type: Article

References (34)

1. Harvey RJ, Skelton-Robinson M, Rossor MN. The prevalence and causes of dementia in people under the age of 65 years. J Neurol Neurosurg Psychiatry 2003;74:1206-1209.
2. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998;51:1546-1554.
3. McKhann GM, Albert MS, Grossman M, et al. Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's disease. Arch Neurol 2001;58:1803-1809.
4. Hodges JR, Salmon DP, Butters N. Semantic memory impairment in Alzheimer disease: failure of access or degraded knowledge? Neuropsychologia 1992;30:301-314.
5. Cairns NJ, Bigio EH, Mackenzie IRA, et al. Neuropatho-logic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Fron-totemporal Lobar Degeneration. Acta Neuropathol 2007; 114:5-22.
6. Fox NC, Black RS, Gilman S, et al. AN1792(QS-21)-201 Study: effects of Abeta immunization (AN1792) on MRI measures of cerebral volume in Alzheimer disease. Neurology 2005;64:1563-1572.
7. Fox NC, Schott JM, Frost C, Rossor MN. Serial magnetic resonance imaging as an outcome measure in dementia. Neurobiol Aging 2004;25:S49.
8. Thal LJ, Kantarci K, Reiman EM, et al. The role of bi-omarkers in clinical trials for Alzheimer disease. Alzheimer Dis Assoc Disord 2006;20:6-15.
9. Beck J, Rohrer JD, Campbell T, et al. A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series. Brain 2008;131:706-720.
10. Pickering-Brown SM. The complex aetiology of fronto-temporal lobar degeneration. Exp Neurol 2007;206:1-10.
11. Chow TW, Miller BL, Hayashi VN, Geschwind DH. Inheritance of frontotemporal dementia. Arch Neurol 1999; 56:817-822.
12. Knopman DS, Kramer JH, Boeve BF, et al. Development of methodology for conducting clinical trials in frontotem-poral lobar degeneration. Brain 2008;131:2957-2968.
13. Knopman DS, Jack CR, Kramer JH, et al. Brain and ventricular volumetric changes in frontotemporal lobar degeneration over 1 year. Neurology 2009;72:1843-1849.
14. Gorno-Tempini ML, Brambati SM, Ginex V, et al. The logopenic/phonological variant of primary progressive aphasia. Neurology 2008;71:1227-1234.
15. Román GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260.
16. Rohrer JD, McNaught E, Foster J, et al. Tracking progression in frontotemporal lobar degeneration: serial MRI in semantic dementia. Neurology 2008;71:1445-1451.
17. Davies RR, Kipps CM, Mitchell J, et al. Progression in frontotemporal dementia: identifying a benign behavioral variant by magnetic resonance imaging. Arch Neurol 2006;63:1627-1631.
18. Kipps CM, Hodges JR, Fryer TD, Nestor PJ. Combined magnetic resonance imaging and positron emission tomography brain imaging in behavioural variant frontotem-poral degeneration: refining the clinical phenotype. Brain 2009;132:2566-2578.
19. Freeborough PA, Fox NC, Kitney RI. Interactive algorithms for the segmentation and quantitation of 3-D MRI brain scans. Comput Methods Programs Biomed 1997;53: 15-25.
20. Freeborough PA, Fox NC. The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI. IEEE Trans Med Imaging 1997;16:623-629.
21. Mazziotta JC, Toga AW, Evans A, Fox P, Lancaster J. A probabilistic atlas of the human brain: theory and rationale for its development. Neuroimage 1995;2:89-101.
22. Freeborough PA, Woods RP, Fox NC. Accurate registration of serial 3D MR brain images and its application to visualizing change in neurodegenerative disorders. J Com-put Assist Tomogr 1996;20:1012-1022.
23. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
24. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a frontal assessment battery at bedside. Neurology 2000;55: 1621-1626.
25. Morris JC. The Clinical Dementia Rating Scale (CDR): current version and scoring rules. Neurology 1993;43: 2412-2414.
26. Kaufer DI, Cummings JL, Christine D, et al. Assessing the impact of neuropsychiatric symptoms in Alzheimer's disease: The Neuropsychiatric Inventory caregiver distress scale. J Am Geriatr Soc 1998;46:210-215.
27. Fox NC, Cousens S, Scahill R, Harvey RJ, Rossor MN. Using serial registered brain magnetic resonance imaging to measure disease progression in Alzheimer disease: power calculations and estimates of sample size to detect treatment effects. Arch Neurol 2000;57:339-344.
28. Kirkwood BR. Essentials of Medical Statistics. Oxford, England: Blackwell Science Ltd.; 1988.
29. Chan D, Fox NC, Scahill RI, et al. Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease. Ann Neurol 2001;49:433-442.
30. Whitwell JL, Jack CR, Parisi JE, et al. Rates of cerebral atrophy differ in different degenerative pathologies. Brain 2007;130:1148-1158.
31. Davies RR, Hodges JR, Kril JJ, Patterson K, Halliday GM, Xuereb JH. The pathological basis of semantic dementia. Brain 2005;128:1984-1995.
32. Rossor MN, Revesz T, Lantos PL, Warrington EK. Semantic dementia with ubiquitin-positive tau-negative inclusion bodies. Brain 2000;123:267-276.
33. Josephs KA, Duffy JR, Strand EA, et al. Clinicopathologi-cal and imaging correlates of progressive aphasia and apraxia of speech. Brain 2006;129:1385-1398.
34. Krueger CE, Dean DL, Rosen HJ, et al. Longitudinal rates of lobar atrophy in frontotemporal dementia, semantic dementia and Alzheimer's disease. Alzheimer Dis Assoc Dis-ord Epub 2009 Jun 30.